Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

0P3C

Karolinska Development Ab (0P3C)

Karolinska Development Ab
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:0P3C
DatumZeitQuelleÜberschriftSymbolFirma
16/05/202416h40UK RegulatoryKarolinska Development’s Annual General Meeting 2024LSE:0P3CKarolinska Development Ab
08/05/202409h30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition initiates second part of clinical phase 1a/2 study in PBCLSE:0P3CKarolinska Development Ab
26/04/202408h00UK RegulatoryInterim Report - January-March 2024LSE:0P3CKarolinska Development Ab
16/04/202408h00UK RegulatoryNotice of Annual General Meeting in Karolinska Development AB (publ)LSE:0P3CKarolinska Development Ab
22/03/202409h30UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents positive safety data from the first part of its Phase 1b/2 study in PBCLSE:0P3CKarolinska Development Ab
22/03/202408h00UK RegulatoryKarolinska Development Annual Report 2023 publishedLSE:0P3CKarolinska Development Ab
14/03/202412h48UK RegulatoryKarolinska Development’s portfolio company Aprea Therapeutics receives FDA IND approval and secures funding of USD 34 millionLSE:0P3CKarolinska Development Ab
14/03/202411h24UK RegulatoryKarolinska Development’s portfolio company Biosergen publishes prospectus due to rights issue of unitsLSE:0P3CKarolinska Development Ab
06/03/202409h00UK RegulatoryKarolinska Development’s portfolio company Umecrine Cognition presents preclinical Parkinson’s data on golexanolone at AD/PDLSE:0P3CKarolinska Development Ab
16/02/202408h00UK RegulatoryYear-end Report - January-December 2023LSE:0P3CKarolinska Development Ab
 Showing the most relevant articles for your search:LSE:0P3C